Showing results (511-520 of 3,032) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|July 2, 2025
Primary hypertension in German children and adolescents: Low treatment rates and dominance of ACE inhibitors in an analysis of 7,482 cases for the period 2005 to 2023Jacob Christian Moll, Jens Bohlken, Kerstin Weber, et al.International Journal of Clinical Pharmacology and Therapeutics|January 9, 2026
Impact of extracorporeal membrane oxygenation on antituberculosis drug concentrations: A case study and pharmaceutical care strategiesYidan Xu, Fei Lv, Xing YuInternational Journal of Clinical Pharmacology and Therapeutics|April 30, 2025
Augmented renal clearance in neurosurgical patients receiving vancomycin: Limited prognostic value for the duration of hospitalization, treatment course, fever, and changes in the CSF test and CRPLu Sun, Yunchuan SunInternational Journal of Clinical Pharmacology and Therapeutics|December 5, 2025
Adverse reactions of PD-1/PD-L1 inhibitors in cancer: FEARS database analysis and protocols to mitigate immune-related events in elderly patients and when using pembrolizumab and atezolizumabSaizhu He, Jingyi Chen, Liming Gu, et al.International Journal of Clinical Pharmacology and Therapeutics|December 5, 2025
Comparison of vasopressin-first weaning versus norepinephrine-first weaning in critically ill patientsMaram Alshreef, Hanin AbaAlkhayl, Qoot Almdainy, et al.International Journal of Clinical Pharmacology and Therapeutics|September 18, 2025
Analgesia using sufentanil and sufentanil plus dexmedetomidine following cesarean section and effect on placental hypoxia-inducible factorsXiaoling Lv, Xiaoping Lin, Long MaInternational Journal of Clinical Pharmacology and Therapeutics|September 18, 2013
Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapyTakeo Yasu, Noriko Sato, Yosuke Kurokawa, et al.International Journal of Clinical Pharmacology and Therapeutics|September 18, 2013
The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among JordaniansKarem H Alzoubi, Omar F Khabour, Sayer I Al-Azzam, et al.International Journal of Clinical Pharmacology and Therapeutics|July 19, 2014
Investigation of the relationship between a starting dose in first-in-human studies and no observed adverse effect level in nonclinical studiesAkihide Sato, Mamoru NarukawaInternational Journal of Clinical Pharmacology and Therapeutics|July 29, 2014
Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic optionRicardo Gómez-Huelgas, Sharona Azriel, Manel Puig-Domingo, et al.Pageof 304